| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.7M | +42.6% |
| Cost of Revenue | $13.6M | +49.5% |
| R&D Expense | $4.8M | +61.1% |
| SG&A Expense | $15.2M | +53.9% |
| Operating Income | -$19.1M | -66.5% |
| Interest Expense | $5.4M | -12.1% |
| Income Tax | $0 | — |
| Net Income | -$24.1M | -237.2% |
| EPS (Basic) | -$1.49 | -109.9% |
| EPS (Diluted) | -$1.49 | -109.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | -60.0% |
| Accounts Receivable | $3.8M | +35.0% |
| Inventory | $2.0M | +218.6% |
| Current Assets | $14.3M | -32.6% |
| Total Assets | $26.3M | -20.8% |
| Current Liabilities | $14.3M | +102.3% |
| Long-term Debt | $186K | -24.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.1M | -57.5% |
| Capital Expenditures | $1.5M | +8.4% |
| Investing Cash Flow | -$1.5M | -8.4% |
| Financing Cash Flow | $8.7M | -66.4% |
| Free Cash Flow | -$17.6M | -51.8% |
| Total Liabilities |
| $52.9M |
| -1.5% |
| Stockholders' Equity | -$38.2M | -86.2% |